Reversible photocyclization of imidazoleisoindole-based stilbene derivative apparently over non-triene form

31 May 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Diarylethene is one of the most extensively studied photochromic compounds due to its remarkable properties. Recently, nitrogen-based diarylethenes have been reported to exhibit unusual photochromic behavior. In this study, we synthesized an imidazoleisoindole-based stilbene analogue, which involves a neutral C=C-C=C-C-N framework along with C=C-C=C-C=N form as a minor mesomeric bipolar form. Crystal structural analysis supported major contribution of the former from. Surprisingly, the molecule exhibited not only E–Z photoisomerization but also the photocyclization with photochemical quantum yields over 0.3 for cyclization reaction. These values are comparable to the usual diarylethenes. The symmetry of the HOMO and LUMO orbitals around the reactive center closely resembled to that of typical diarylethenes and satisfied the Woodward-Hoffmann rules. Imidazolium analogue is also studied for comparison. The imidazoleisoindole-based stilbene analogue represents a novel and unusual example of photocyclization in diarylethenes, uncovering the importance of the symmetric feature of LUMO and HOMO around the reactive center for the photocyclization.

Keywords

photochromism
peri cyclization
imidazole
imidazolium

Supplementary materials

Title
Description
Actions
Title
SI-Reversible Photocyclization of Imidazoleisoindole-Based Stilbene Derivative Apparently over Non-Triene Form
Description
Syntheses, NMR, Mass, X-ray and quantum chemical calculations are presented.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.